All of the above. CKD meets the WHO principles of screening for disease. Early screening is also considered essential for social equality and useful for identifying high risk cases for CKD progression6
GFR and albuminuria are considered essential biochemical parameters used in the KDIGO matrix define CKD7
G3aA2. According to the 2012 KDIGO guidelines, an eGFR of 45–59 and an albuminuria level of 3–30mg/mmol is indicative of a G3aA2 level of risk for CKD7
Opportunistic screening. This is where a healthcare professional carries out screening during encounters for other medical reasons8
Amelie has a high-risk and treatment should be immediately implemented. G3aA2 is considered high risk. A combination strategy of CKD screening, risk stratification, and treatment should be implemented immediately for people at a high-risk of CKD6